Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Critical Reviews in Clinical Laboratory Sciences|March 7, 2006
Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitorAnnukka Paju, Ulf-Håkan Stenman
Clinical Chemistry|October 29, 2005
Application of proteomic technology in identifying pancreatic secretory trypsin inhibitor variants in urine of patients with pancreatitisLeena Valmu, Annukka Paju, Marko Lempinen, et al.
International Journal of Cancer|February 21, 2003
Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: prognostic study on tissue and serumKristina Hotakainen, Börge Ljungberg, Caj Haglund, et al.
Acta Paediatrica (Oslo, Norway : 1992)|November 24, 2005
New insights into juvenile parotitisKaija-Leena Kolho, Riitta Saarinen, Annukka Paju, et al.
The Journal of Molecular Diagnostics : JMD|October 27, 2006
Expression of human chorionic gonadotropin beta-subunit type I genes predicts adverse outcome in renal cell carcinomaKristina Hotakainen, Susanna Lintula, Börje Ljungberg, et al.
European Urology|June 21, 2002
Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissueKristina Hotakainen, Caj Haglund, Annukka Paju, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 2, 2006
Overexpression of human chorionic gonadotropin beta genes 3, 5 and 8 in tumor tissue and urinary cells of bladder cancer patientsKristina Hotakainen, Susanna Lintula, Riikka Jarvinen, et al.
The Prostate|January 15, 2005
Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancerAnders Bjartell, Annukka Paju, Wan-Ming Zhang, et al.
The Prostate|January 30, 2002
Prostate-specific antigen and other prostate-derived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3Hannu Koistinen, Annukka Paju, Riitta Koistinen, et al.
European Urology|February 20, 2007
Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cellsAnnukka Paju, Kristina Hotakainen, Yue Cao, et al.
Pageof 2